Extension Letter Amendment to Consulting Agreement between AVEO Pharmaceuticals, Inc. and Ronald A. DePinho, MD (March 30, 2011)

Summary

AVEO Pharmaceuticals, Inc. and Dr. Ronald A. DePinho have agreed to extend the term of their existing Consulting Agreement. The amendment, effective January 1, 2011, extends the consultation period through December 31, 2011, unless terminated earlier as specified in the original agreement. All other terms and obligations remain unchanged.

EX-10.1 2 dex101.htm EXTENSION LETTER AMENDMENT, DATED MARCH 30, 2011 - RON DEPINHO Extension Letter Amendment, dated March 30, 2011 - Ron DePinho

Exhibit 10.1

75 Sidney Street, 4th Floor

Cambridge, MA 02139

Phone: 617 ###-###-####

Fax: 617 ###-###-####

March 30, 2011

Ronald A. DePinho, MD

89 Hyslop Road

Brookline, MA 02445

 

Re: Consulting Agreement by and between Ronald A. DePihno, MD and AVEO Pharmaceuticals, Inc effective as of January 1, 2010 (the “Consulting Agreement”)

Dear Dr. DePinho,

It is hereby agreed that Section 2 of the Consulting Agreement shall be amended, effective as of January 1, 2011, to extend the Consultation Period through and including December 31, 2011 unless sooner terminated in accordance with Section 11 of the Consultant Agreement. All other terms and obligations under the Consulting Agreement shall remain the same.

Sincerely,

/s/ Murray O. Robinson

Murray O. Robinson, PhD

Senior Vice President, Translational Research

Co-chair of the Scientific Advisory Board

Agreed and Acknowledged:

 /s/ Ronald A. DePinho
Ronald A. DePinho, MD